Washington, DC - The U.S. Food and Drug Administration approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Washington, DC - Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).

Washington, DC - The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

King’s Command Foods, LLC., a Kent, Wash. establishment, is recalling approximately 63,252 pounds of ground beef products that may be contaminated with extraneous materials, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced Friday.

Washington, DC - The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis.

Washington, DC - President Donald J. Trump met with Congressman Elijah Cummings (D-MD) in the Oval Office to discuss rising prescription drug prices. This meeting was a result of a January telephone conversation, during which Congressman Cummings said that he and the President, “had more in common than differences.”